NCT03029078

FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Centre d'Investigation Clinique et Technologique 805 · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Our trial try to eradicate digestive tract colonization of patient harboring Extreme Drug Resistant (XDR) bacteria by performing a fecal transplantation.

Detailed description

Main objective: Evaluate the eradication of the colonization of patient harboring XDR bacteria after a fecal transplantation from a healthy donor. Secondary objectives: English Evaluate the side effects of this procedure and tolerability. Evaluate the efficacy of the transplant if the patient is harboring glycopeptid resistant enteroccus (GRE) or carbapenem resistant enterobacteriae (CRE)

Conditions

• Microbial Colonization
• Bacterial Peritonitis
• Faeces Smearing

Interventions

Type	Name	Description
DRUG	fecal microbiota transplant	We will perform a fecal microbiota transplant for patients harboring XDR bacteria in their digestive tract

Timeline

• Start date: 2014-11-01
• Primary completion: 2020-12-01
• Completion: 2020-12-01
• First posted: 2017-01-24
• Last updated: 2021-07-27

Locations

1 site across 1 country: France